FATE NASDAQ
Fate Therapeutics, Inc.
1W: -1.3%
1M: -5.3%
3M: -22.4%
YTD: +107.1%
1Y: +109.0%
3Y: -12.8%
5Y: -97.3%
$2.32
+0.02 (+0.87%)
Weekly Expected Move ±5.8%
$2
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$6M
Revenue
-23.4% YoY
$-126M
Net Income
+26.5% YoY
$-106M
Free Cash Flow
+11.0% YoY
100.0%
Gross Margin
-1495.4%
Op. Margin
-1448.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-60.7%
ROA-39.9%
ROIC-140.1%
Valuation
P/E-2.2
P/B1.8
EV/EBITDA-2.1
Leverage
Debt/Equity0.49
Current Ratio4.85
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-7.76
Beneish M-3.66